(Washington, D.C.) — As Congress begins to examine high prescription drug prices, the Pharmaceutical Care Management Association (PCMA) sent letters to several congressional committees highlighting the value pharmacy benefit managers (PBMs) provide to patients and payers as well as outlining
COVID-19: Frequently Asked Questions PBMs have substantial experience helping patients get the drugs and vaccines they need, including in times of crisis. PBMs are taking action to help educate the patients we serve about the safety and efficacy of authorized
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is releasing new research showing that premiums would rise by over 50 percent if Medicare Part D plans are prohibited from negotiating rebates on brand drugs. Manufacturers have chosen to negotiate price concessions with PBMs
In 2018, more than 44 million seniors and people with disabilities are expected to be enrolled in Medicare Part D. The national average premium in 2018 is $35.02, only $2.60 higher than the national average premium in 2014 (representing less
Health care, business, political, and economic experts all agree pharmacy benefit companies deliver significant savings and play a critical role mitigating costs and supporting access to affordable, quality prescription drug coverage for employers and patients. A number of economists, academics,
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
“In effect, the era of high list prices and high rebates for insulin is over” In case you missed it, Alex Brill, founder and CEO of Matrix Global Advisors (MGA) and former policy director and chief economist for the House
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement today ahead of the U.S. House Committee on Oversight and Accountability hearing titled “The Role of Pharmacy Benefit Managers in Prescription Drug Markets
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
©2024 PCMA. All Rights Reserved.
